Prucalopride Improves Bowel Function and Colonic Transit Time in Patients With Chronic Constipation: An Integrated Analysis
Authors:
Open Access
- 1 June 2014
- journal article
- research article
- Published by Wolters Kluwer Health in American Journal of Gastroenterology
- Vol. 109 (6) , 887-894
Abstract
Objectives: Methods: Results: Conclusions:Keywords
This publication has 30 references indexed in Scilit:
- Chronic Idiopathic ConstipationJournal of Clinical Gastroenterology, 2012
- Biofeedback therapy for constipation in adultsBest Practice & Research Clinical Gastroenterology, 2011
- Current management strategies and therapeutic targets in chronic constipationTherapeutic Advances in Gastroenterology, 2010
- Clinical trial: the efficacy, impact on quality of life, and safety and tolerability of prucalopride in severe chronic constipation – a 12‐week, randomized, double‐blind, placebo‐controlled studyAlimentary Pharmacology & Therapeutics, 2008
- Prucalopride (Resolor) in the treatment of severe chronic constipation in patients dissatisfied with laxativesGut, 2008
- Insights Into Normal and Disordered Bowel Habits From Bowel DiariesAmerican Journal of Gastroenterology, 2008
- 5‐HT4receptor agonists: similar but not the sameNeurogastroenterology & Motility, 2008
- The burden of constipation on quality of life: results of a multinational surveyAlimentary Pharmacology & Therapeutics, 2007
- The Health-Related Quality of Life and Economic Burden of ConstipationPharmacoEconomics, 2005
- Irritable bowel-type symptoms in spontaneous and induced constipation.Gut, 1987